Crown (CCK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Adjusted EPS rose 11% year-over-year to $1.86, while reported EPS was $1.56, down from $1.65 last year.
Net sales increased 13% year-over-year to $3,259 million, driven by higher global beverage can volumes, raw material cost pass-through, and favorable FX.
Net income attributable to shareholders was $175 million, down from $193 million year-over-year.
Over $250 million returned to shareholders in Q1, including a 35% dividend increase and $212 million in share repurchases.
Announced a new two-line beverage can plant in Northern India, expected to open in H2 2027, supporting growth in a fast-growing market.
Financial highlights
Adjusted EPS: $1.86 (up 11% YoY); Reported EPS: $1.56 (down from $1.65 YoY).
Net sales: up 13% YoY to $3,259 million, with a 5% increase in global beverage can volumes.
Segment income: $405 million, up from $398 million YoY.
Adjusted EBITDA reached $485 million, up from $473 million.
Cash and cash equivalents at quarter-end were $584 million, down from $764 million at year-end 2025.
Outlook and guidance
Q2 2026 adjusted EPS projected at $2.10–$2.20; full-year guidance at $7.90–$8.30, including a $0.10 headwind from Middle East conflict.
Free cash flow guidance for 2026: ~$900 million after $550 million in capex.
Year-end net leverage expected at 2.5x, in line with long-term targets.
Full-year guidance assumes $355 million net interest expense, 25% tax rate, $330 million depreciation, and $145 million non-controlling interest expense.
No material impact expected from recent U.S. tax reform or OECD Pillar II global minimum tax for 2026.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025